318 reports of this reaction
14.7% of all AVOBENZONE, OCTISALATE, AND OCTOCRYLENE reports
#1 most reported adverse reaction
DRUG INEFFECTIVE is the #1 most commonly reported adverse reaction for AVOBENZONE, OCTISALATE, AND OCTOCRYLENE, manufactured by Alchemee, LLC. There are 318 FDA adverse event reports linking AVOBENZONE, OCTISALATE, AND OCTOCRYLENE to DRUG INEFFECTIVE. This represents approximately 14.7% of all 2,163 adverse event reports for this drug.
Patients taking AVOBENZONE, OCTISALATE, AND OCTOCRYLENE who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is a frequently reported adverse event for AVOBENZONE, OCTISALATE, AND OCTOCRYLENE, accounting for a significant proportion of all reports.
In addition to drug ineffective, the following adverse reactions have been reported for AVOBENZONE, OCTISALATE, AND OCTOCRYLENE:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 318 FDA reports for AVOBENZONE, OCTISALATE, AND OCTOCRYLENE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 14.7% of all adverse event reports for AVOBENZONE, OCTISALATE, AND OCTOCRYLENE, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking AVOBENZONE, OCTISALATE, AND OCTOCRYLENE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.